Global Biological API Drug Manufacturing Market Growth 2023-2029

Global Biological API Drug Manufacturing Market Growth 2023-2029

It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.

LPI (LP Information)' newest research report, the “Biological API Drug Manufacturing Industry Forecast” looks at past sales and reviews total world Biological API Drug Manufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Biological API Drug Manufacturing sales for 2023 through 2029. With Biological API Drug Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological API Drug Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global Biological API Drug Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological API Drug Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biological API Drug Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological API Drug Manufacturing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological API Drug Manufacturing.

The global Biological API Drug Manufacturing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Biological API Drug Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Biological API Drug Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Biological API Drug Manufacturing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Biological API Drug Manufacturing players cover Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM, Samsung BioLogics, Fujifilm Diosynth Biotechnologies, Cytovance Biologics, AbbVie and Baxter, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological API Drug Manufacturing market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
In-House manufacturing
Contract manufacturing

Segmentation by application
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biological API Drug Manufacturing market?

What factors are driving Biological API Drug Manufacturing market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Biological API Drug Manufacturing market opportunities vary by end market size?

How does Biological API Drug Manufacturing break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.